HealthMore in Health→
Study links Medicare insulin cap to lower costs and better access
A study found that Medicare patients spent less on insulin after a $35 monthly cap took effect in 2023, with evidence that more patients adhered to treatment.
Key Takeaways
- A study suggests Medicare patients spent significantly less on insulin after the $35 cap began in 2023.
- The report says more patients appeared to adhere to treatment in the policy’s first year.
DE
DT Editorial Team··via endpoints.news